Life Sciences

GSK joins disclosure parade

Pharma Compliance Alert, October 29, 2008

The list of pharmaceutical companies that will disclose payments to physicians is getting longer. GlaxoSmithKline (GSK) plans to disclose how much funding it provides to physicians and medical schools, according to a Financial Times article. GSK will also cap payments to U.S. physicians at $150,000 per year

Post a Comment

Name:

 

E-mail:

 

Please enter your comment below:

   

Please enter the text below: